Value of automated breast ultrasound in screening: Standalone and as a supplemental to digital breast tomosynthesis
International Journal of Cancer · 2024
DOI: 10.1002/ijc.35093 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Erkin Aribal und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Department of Radiology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Breast Neoplasms, Ultrasonography, Mammary, Mammography, Early Detection of Cancer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GE Healthcare.
Abstract (Originalsprache)
We aimed to determine the value of standalone and supplemental automated breast ultrasound (ABUS) in detecting cancers in an opportunistic screening setting with digital breast tomosynthesis (DBT) and compare this combined screening method to DBT and ABUS alone in women older than 39 years with BI‐RADS B‐D density categories. In this prospective opportunistic screening study, 3466 women aged 39 or older with BI‐RADS B‐D density categories and with a mean age of 50 were included. The screening protocol consisted of DBT mediolateral‐oblique views, 2D craniocaudal views, and ABUS with three projections for both breasts. ABUS was evaluated blinded to mammography findings. Statistical analysis evaluated diagnostic performance for DBT, ABUS, and combined workflows. Twenty‐nine cancers were screen‐detected. ABUS and DBT exhibited the same cancer detection rates (CDR) at 7.5/1000 whereas DBT + ABUS showed 8.4/1000, with ABUS contributing an additional CDR of 0.9/1000. Standalone ABUS outperformed DBT in detecting 12.5% more invasive cancers. DBT displayed better accuracy (95%) compared to ABUS (88%) and combined approach (86%). Sensitivities for DBT and ABUS were the same (84%), with DBT + ABUS showing a higher rate (94%). DBT outperformed ABUS in specificity (95% vs. 88%). DBT + ABUS exhibited a higher recall rate (14.89%) compared to ABUS (12.38%) and DBT (6.03%) ( p < .001). Standalone ABUS detected more invasive cancers compared to DBT, with a higher recall rate. The combined approach showed a higher CDR by detecting one additional cancer per thousand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Department of Radiology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
- Department of Radiology, Acibadem Altunizade Hospital, Istanbul, Turkey.
ORCID-Profile: Erkin Aribal, Mustafa Ege Seker, Nilgün Guldogan, Ebru Yilmaz
Förderung
- GE Healthcare
Zitieren
APA
Aribal, E., Seker, M. E., Guldogan, N., & Yilmaz, E. (2024). Value of automated breast ultrasound in screening: Standalone and as a supplemental to digital breast tomosynthesis. International Journal of Cancer. https://doi.org/10.1002/ijc.35093
Vancouver
Aribal E, Seker ME, Guldogan N, Yilmaz E. Value of automated breast ultrasound in screening: Standalone and as a supplemental to digital breast tomosynthesis. International Journal of Cancer. 2024. doi:10.1002/ijc.35093
BibTeX
@article{Aribal2024,
author = {Aribal, Erkin and Seker, Mustafa Ege and Guldogan, Nilgün and Yilmaz, Ebru},
title = {Value of automated breast ultrasound in screening: Standalone and as a supplemental to digital breast tomosynthesis},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.35093}
}
EUVIMED